Annals of Emergency Medicine · 2003 · 33 citations · 19 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyNeoplasiaMrna StabilityMyc Family OncogenesTranslation ControlTranslation RegulationTranslational RegulationUntranslated RegionsBenign Breast TumorsBenign Mesenchymal TumorsBreast FibroadenomaC-myc RegulationEndonucleolytic Rna CleavageMyc OncogenesMyc Stability ControlMyc Transcriptional Repression
The Coding Region Determinant-Binding Protein (CRD-BP) is an RRM and KH-domain-containing protein that recognizes specifically at least three RNAs. It binds to one of the two c-myc mRNA instability elements, to the 5'Un Translated Region (UTR) of the leader 3 IGF-II mRNA and to the oncofetal H19 RNA. CRD-BP has been assigned a role in stabilizing c-myc mRNA by preventing its endonucleolytic cleavage and in repressing the translation of the leader 3 IGF-II mRNA, the major embryonic species of this message. CRD-BP is normally expressed only in fetal tissues. However, its expression is detected in primary tumors and transformed cell lines of different origins. The vast majority of colon (80%) and breast (60%) tumors and sarcomas (73%) express CRD-BP whereas in other tumor types, for example prostate carcinomas, its expression is rare. CRD-BP expression has also been detected in benign tumors such as breast fibroadenomas, meningiomas and other benign mesenchymal tumors, implying a role for this gene in abnormal cell proliferation. In breast carcinomas, CRD-BP expression and or gene copy number gains in the region encompassing the c-myc locus were detected in approximately 75% of tumors, implying that the deregulated expression of c-myc may be more widespread than previously believed. Infiltrated lymph nodes, corresponding to CRD-BP-positive primary tumors, were also found positive indicating that monitoring for CRD-BP could prove useful for the detection and monitoring of disseminated disease.
19
Clinical Significance of Reported Changes in Pain Severity☆☆☆★
Knox H. Todd, Kathleen G Funk, Joseph P Funk et al. · Annals of Emergency Medicine · 1996 · 1.1K citations
Yoshitsugu Yanagihara, Michiteru Ohtani, Satoru Kariya et al. · Biopharmaceutics & Drug Disposition · 2002 · 214 citations